Metabolomic Profiling in Neuromyelitis Optica Spectrum Disorder Biomarker Discovery

There is no specific test for diagnosing neuromyelitis optica spectrum disorder (NMOSD), a disabling autoimmune disease of the central nervous system. Instead, diagnosis relies on ruling out other related disorders with overlapping clinical symptoms. An urgency for NMOSD biomarker discovery is under...

Descripción completa

Detalles Bibliográficos
Autores principales: Thoman, Maxton E., McKarns, Susan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570337/
https://www.ncbi.nlm.nih.gov/pubmed/32961928
http://dx.doi.org/10.3390/metabo10090374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570337/
https://www.ncbi.nlm.nih.gov/pubmed/32961928
http://dx.doi.org/10.3390/metabo10090374

Ejemplares similares